Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 13, 2023

SELL
$2.96 - $10.72 $497 - $1,800
-168 Reduced 96.0%
7 $0
Q1 2022

Apr 14, 2022

SELL
$0.52 - $1.3 $91 - $227
-175 Reduced 50.0%
175 $0
Q3 2020

Nov 06, 2020

BUY
$1.86 - $3.15 $651 - $1,102
350 New
350 $1,000

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.04M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.